Company / Operating Income per Share
BioXcel Therapeutics, Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$16.27
FY2025
5-year range
-$91.81 / -$3.82
FY2022-FY2025
Trend
+82.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-16.27.
Based on SEC 10-K filings.
-16.27 in FY2025.
Declined from $-5.67 to $-16.27 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 82.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.27 | +82.3% |
| FY2024 | -$91.81 | -1518.8% |
| FY2023 | -$5.67 | -48.4% |
| FY2022 | -$3.82 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026